• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于预测扩张型心肌病患者左心室逆向重构的临床评分

A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy.

作者信息

Kimura Yuki, Okumura Takahiro, Morimoto Ryota, Kazama Shingo, Shibata Naoki, Oishi Hideo, Araki Takashi, Mizutani Takashi, Kuwayama Tasuku, Hiraiwa Hiroaki, Kondo Toru, Murohara Toyoaki

机构信息

Department of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

出版信息

ESC Heart Fail. 2021 Apr;8(2):1359-1368. doi: 10.1002/ehf2.13216. Epub 2021 Jan 20.

DOI:10.1002/ehf2.13216
PMID:33471966
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8006712/
Abstract

AIMS

Left ventricular reverse remodelling (LVRR) is a well-established predictor of a good prognosis in patients with dilated cardiomyopathy (DCM). The prediction of LVRR is important when developing a long-term treatment strategy. This study aimed to assess the clinical predictors of LVRR and establish a scoring system for predicting LVRR in patients with DCM that can be used at any institution.

METHODS AND RESULTS

We consecutively enrolled 131 patients with DCM and assessed the clinical predictors of LVRR. LVRR was defined as an absolute increase in left ventricular ejection fraction (LVEF) from ≥10% to a final value of >35%, accompanied by a decrease in left ventricular end-diastolic dimension (LVEDD) ≥ 10% on echocardiography at 1 ± 0.5 years after a diagnosis of DCM. The mean patient age was 50.1 ± 11.9 years. The mean LVEF was 32.2 ± 9.5%, and the mean LVEDD was 64.1 ± 12.5 mm at diagnosis. LVRR was observed in 45 patients (34%) at 1 ± 0.5 years. In a multivariate analysis, hypertension [odds ratio (OR): 6.86; P = 0.002], no family history of DCM (OR: 10.45; P = 0.037), symptom duration <90 days (OR: 6.72; P < 0.001), LVEF <35% (OR: 13.66; P < 0.0001), and QRS duration <116 ms (OR: 5.94; P = 0.005) were found to be independent predictors of LVRR. We scored the five independent predictors according to the ORs (1 point, 2 points, 1 point, 2 points, and 1 point, respectively), and the total LVRR predicting score was calculated by adding these scores. The LVRR rate was stratified by the LVRR predicting score (0-2 points: 0%; 3 points: 6.7%; 4 points: 17.4%; 5 points: 48.2%; 6 points: 79.2%; and 7 points: 100%). The cut-off value of the LVRR predicting score was >5 in receiver-operating characteristic curve analysis (area under the curve: 0.89; P < 0.0001; sensitivity: 87%; specificity: 78%). An LVRR predicting score of >5 was an independent predictor compared with the presence of late gadolinium enhancement on cardiovascular magnetic resonance or the severity of fibrosis on endomyocardial biopsy (OR: 11.79; 95% confidence interval: 2.40-58.00; P = 0.002).

CONCLUSIONS

The LVRR predicting score using five predictors including hypertension, no family history of DCM, symptom duration <90 days, LVEF <35%, and QRS duration <116 ms can stratify the LVRR rate in patients with DCM. The LVRR predicting score may be a useful clinical tool that can be used easily at any institution.

摘要

目的

左心室逆向重构(LVRR)是扩张型心肌病(DCM)患者预后良好的公认预测指标。在制定长期治疗策略时,LVRR的预测很重要。本研究旨在评估LVRR的临床预测因素,并建立一个可在任何机构使用的DCM患者LVRR预测评分系统。

方法与结果

我们连续纳入了131例DCM患者,并评估了LVRR的临床预测因素。LVRR定义为在DCM诊断后1±0.5年时,经超声心动图检查,左心室射血分数(LVEF)绝对增加≥10%至最终值>35%,同时左心室舒张末期内径(LVEDD)减少≥10%。患者平均年龄为50.1±11.9岁。诊断时平均LVEF为32.2±9.5%,平均LVEDD为64.1±12.5mm。在1±0.5年时,45例患者(34%)出现LVRR。多因素分析显示,高血压[比值比(OR):6.86;P=0.002]、无DCM家族史(OR:10.45;P=0.037)、症状持续时间<90天(OR:6.72;P<0.001)、LVEF<35%(OR:13.66;P<0.0001)以及QRS波时限<116ms(OR:5.94;P=0.005)是LVRR的独立预测因素。我们根据OR值对这五个独立预测因素进行评分(分别为1分、2分、1分、2分和1分),并通过将这些分数相加计算出LVRR预测总分。根据LVRR预测评分对LVRR发生率进行分层(0 - 2分:0%;3分:6.7%;4分:17.4%;5分:48.2%;6分:79.2%;7分:100%)。在受试者工作特征曲线分析中,LVRR预测评分的截断值>5(曲线下面积:0.89;P<0.0001;敏感性:87%;特异性:78%)。与心血管磁共振成像上延迟钆增强的存在或心内膜心肌活检中纤维化的严重程度相比,LVRR预测评分>5是一个独立的预测因素(OR:11.79;95%置信区间:2.40 - 58.00;P=0.002)。

结论

使用包括高血压、无DCM家族史、症状持续时间<90天、LVEF<35%和QRS波时限<116ms这五个预测因素的LVRR预测评分,可以对DCM患者的LVRR发生率进行分层。LVRR预测评分可能是一种有用的临床工具,可在任何机构轻松使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8927/8006712/238828b16317/EHF2-8-1359-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8927/8006712/0e563e8aeb54/EHF2-8-1359-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8927/8006712/238828b16317/EHF2-8-1359-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8927/8006712/0e563e8aeb54/EHF2-8-1359-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8927/8006712/238828b16317/EHF2-8-1359-g002.jpg

相似文献

1
A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy.一种用于预测扩张型心肌病患者左心室逆向重构的临床评分
ESC Heart Fail. 2021 Apr;8(2):1359-1368. doi: 10.1002/ehf2.13216. Epub 2021 Jan 20.
2
Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy.扩张型心肌病左心室功能改善的临床表型和基因型相关性。
Circ Heart Fail. 2018 Nov;11(11):e005220. doi: 10.1161/CIRCHEARTFAILURE.118.005220.
3
Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy.新发扩张型心肌病患者左心室逆重构的新预测因子。
J Am Coll Cardiol. 2013 Jan 8;61(1):54-63. doi: 10.1016/j.jacc.2012.07.072.
4
Relations between circulating and myocardial fibrosis-linked microRNAs with left ventricular reverse remodeling in dilated cardiomyopathy.循环和心肌纤维化相关 microRNAs 与扩张型心肌病左心室逆重构的关系。
Adv Clin Exp Med. 2020 Mar;29(3):285-293. doi: 10.17219/acem/115088.
5
[Predictive factors of left ventricular reverse remodeling in patients with idiopathic or secondary dilated cardiomyopathy].[特发性或继发性扩张型心肌病患者左心室逆向重构的预测因素]
Nan Fang Yi Ke Da Xue Xue Bao. 2018 Jan 30;38(1):81-88. doi: 10.3969/j.issn.1673-4254.2018.01.13.
6
Myocardial Tissue Reverse Remodeling After Guideline-Directed Medical Therapy in Idiopathic Dilated Cardiomyopathy.特发性扩张型心肌病患者接受指南指导的药物治疗后的心肌组织逆向重构。
Circ Heart Fail. 2021 Jan;14(1):e007944. doi: 10.1161/CIRCHEARTFAILURE.120.007944. Epub 2020 Nov 13.
7
The potential predictive value of cardiac mechanics for left ventricular reverse remodelling in dilated cardiomyopathy.心脏力学对扩张型心肌病左心室逆重构的潜在预测价值。
ESC Heart Fail. 2023 Dec;10(6):3340-3351. doi: 10.1002/ehf2.14529. Epub 2023 Sep 12.
8
Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy.心内膜心肌活检联合心脏磁共振成像预测特发性扩张型心肌病左心室逆向重构的临床意义
Heart Vessels. 2016 Dec;31(12):1960-1968. doi: 10.1007/s00380-016-0815-0. Epub 2016 Feb 26.
9
Incidence and prognosis implications of long term left ventricular reverse remodeling in patients with dilated cardiomyopathy.扩张型心肌病患者长期左心室逆向重构的发生率及其对预后的影响
Int J Cardiol. 2016 Jan 15;203:1114-21. doi: 10.1016/j.ijcard.2015.11.099. Epub 2015 Nov 17.
10
Long-term outcomes and reverse remodelling in recently diagnosed unexplained left ventricular systolic dysfunction.近期诊断的不明原因左心室收缩功能障碍的长期预后和逆重构。
ESC Heart Fail. 2024 Apr;11(2):859-870. doi: 10.1002/ehf2.14643. Epub 2024 Jan 10.

引用本文的文献

1
Prognostic implications of left ventricular mechanical dispersion in comparison with QRS duration in heart failure with reduced ejection fraction.射血分数降低的心力衰竭患者中,左心室机械离散度与QRS波时限相比的预后意义。
Quant Imaging Med Surg. 2025 Aug 1;15(8):7510-7523. doi: 10.21037/qims-24-2324. Epub 2025 Jul 30.
2
A predictive model for left ventricular reverse remodeling after pharmacological therapy in children with recent-onset dilated cardiomyopathy.近期发病的扩张型心肌病患儿药物治疗后左心室逆向重构的预测模型。
PLoS One. 2025 Apr 1;20(4):e0321126. doi: 10.1371/journal.pone.0321126. eCollection 2025.
3

本文引用的文献

1
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.急性心肌炎和慢性炎症性心肌病的管理:专家共识文件。
Circ Heart Fail. 2020 Nov;13(11):e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405. Epub 2020 Nov 12.
2
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.心肌炎和炎性心肌病:当前的证据和未来的方向。
Nat Rev Cardiol. 2021 Mar;18(3):169-193. doi: 10.1038/s41569-020-00435-x. Epub 2020 Oct 12.
3
Prognosis and Clinical Characteristics of Dilated Cardiomyopathy With Family History via Pedigree Analysis.
Electron microscopic findings predict clinical outcomes in patients with non-ischaemic cardiomyopathy.
电子显微镜检查结果可预测非缺血性心肌病患者的临床结局。
ESC Heart Fail. 2025 Aug;12(4):2441-2449. doi: 10.1002/ehf2.15255. Epub 2025 Mar 2.
4
Late Gadolinium Enhancement Magnetic Resonance Imaging (MRI) for Predicting Left Ventricular Reverse Remodeling in Non-Ischemic Cardiomyopathy: A Systematic Review and Meta-Analysis.钆增强磁共振成像(MRI)预测非缺血性心肌病左心室逆向重构:一项系统评价和荟萃分析
J Clin Med. 2025 Jan 29;14(3):895. doi: 10.3390/jcm14030895.
5
Recent Trends in Achievement Rates and Time Required for Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy.扩张型心肌病左心室逆向重构的成功率及所需时间的近期趋势
Circ Rep. 2025 Jan 8;7(2):97-105. doi: 10.1253/circrep.CR-24-0148. eCollection 2025 Feb 10.
6
Prognostic value of advanced lung cancer inflammation index in heart failure patients: A comprehensive analysis.晚期肺癌炎症指数在心力衰竭患者中的预后价值:一项综合分析。
ESC Heart Fail. 2025 Jun;12(3):2298-2309. doi: 10.1002/ehf2.15178. Epub 2024 Dec 3.
7
Diverse Concepts in Definitions of Dilated Cardiomyopathy: Theory and Practice.扩张型心肌病定义中的不同概念:理论与实践
Cardiol Res. 2024 Oct;15(5):319-329. doi: 10.14740/cr1679. Epub 2024 Sep 16.
8
Beyond the Initial Insult: Clinical Characteristics and Prognosis of Heart Failure with Improved Ejection Fraction.初始损伤之外:射血分数改善的心力衰竭的临床特征与预后
Cardiology. 2025;150(2):147-154. doi: 10.1159/000540597. Epub 2024 Jul 26.
9
Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers.从心肌病到心肌存活的短暂性左心室功能障碍:心脏功能何时恢复及为何恢复。
Biomedicines. 2024 May 9;12(5):1051. doi: 10.3390/biomedicines12051051.
10
Restrictive annuloplasty or replacement on reverse remodeling for nonischemic dilated cardiomyopathy.限制型瓣环成形术或置换术治疗非缺血性扩张型心肌病的逆重构。
J Cardiothorac Surg. 2024 Apr 12;19(1):201. doi: 10.1186/s13019-024-02719-6.
通过家系分析探讨有家族史的扩张型心肌病的预后和临床特征。
Circ J. 2020 Jul 22;84(8):1284-1293. doi: 10.1253/circj.CJ-19-1176. Epub 2020 Jul 3.
4
Predictors of left ventricular remodelling in patients with dilated cardiomyopathy - a cardiovascular magnetic resonance study.扩张型心肌病患者左心室重构的预测因素 - 一项心血管磁共振研究。
Eur J Heart Fail. 2020 Jul;22(7):1160-1170. doi: 10.1002/ejhf.1734. Epub 2020 Feb 13.
5
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction.非缺血性扩张型心肌病射血分数以外的心律失常风险分层。
Heart. 2020 May;106(9):656-664. doi: 10.1136/heartjnl-2019-315942. Epub 2020 Jan 21.
6
Quantification of DNA Damage in Heart Tissue as a Novel Prediction Tool for Therapeutic Prognosis of Patients With Dilated Cardiomyopathy.心脏组织中DNA损伤的定量分析作为扩张型心肌病患者治疗预后的新型预测工具
JACC Basic Transl Sci. 2019 Sep 25;4(6):670-680. doi: 10.1016/j.jacbts.2019.05.010. eCollection 2019 Oct.
7
Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy.扩张型心肌病左心室功能改善的临床表型和基因型相关性。
Circ Heart Fail. 2018 Nov;11(11):e005220. doi: 10.1161/CIRCHEARTFAILURE.118.005220.
8
Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives.扩张型心肌病中的逆向重构:见解与未来展望。
Int J Cardiol Heart Vasc. 2018 Mar 8;18:52-57. doi: 10.1016/j.ijcha.2018.02.005. eCollection 2018 Mar.
9
The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis.晚期钆增强心脏磁共振成像在非缺血性扩张型心肌病中的预后价值:综述和荟萃分析。
JACC Cardiovasc Imaging. 2018 Sep;11(9):1274-1284. doi: 10.1016/j.jcmg.2018.03.006. Epub 2018 Apr 18.
10
Mortality and Sudden Cardiac Death Risk Stratification Using the Noninvasive Combination of Wide QRS Duration and Late Gadolinium Enhancement in Idiopathic Dilated Cardiomyopathy.采用宽 QRS 持续时间和心脏磁共振钆延迟增强的无创联合方法对特发性扩张型心肌病患者的死亡率和心源性猝死风险进行分层。
Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e006233. doi: 10.1161/CIRCEP.117.006233.